Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

Europe - EPA:ALNSE - FR0004065639 - Common Stock

43 EUR
-0.3 (-0.69%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

6

Overall ALNSE gets a fundamental rating of 6 out of 10. We evaluated ALNSE against 48 industry peers in the Aerospace & Defense industry. While ALNSE has a great health rating, its profitability is only average at the moment. ALNSE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ALNSE had positive earnings in the past year.
ALNSE had a positive operating cash flow in the past year.
ALNSE had positive earnings in each of the past 5 years.
ALNSE had a positive operating cash flow in 4 of the past 5 years.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.15%, ALNSE is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
ALNSE has a Return On Equity (8.69%) which is comparable to the rest of the industry.
ALNSE's Return On Invested Capital of 10.97% is fine compared to the rest of the industry. ALNSE outperforms 68.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALNSE is in line with the industry average of 9.20%.
The 3 year average ROIC (9.24%) for ALNSE is below the current ROIC(10.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROIC 10.97%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

ALNSE has a Profit Margin (3.50%) which is comparable to the rest of the industry.
ALNSE's Profit Margin has declined in the last couple of years.
The Operating Margin of ALNSE (6.85%) is worse than 66.67% of its industry peers.
ALNSE's Operating Margin has declined in the last couple of years.
ALNSE has a better Gross Margin (43.87%) than 70.83% of its industry peers.
ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

ALNSE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALNSE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALNSE has more shares outstanding
ALNSE has a better debt/assets ratio than last year.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.37 indicates that ALNSE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.37, ALNSE belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
The Debt to FCF ratio of ALNSE is 0.65, which is an excellent value as it means it would take ALNSE, only 0.65 years of fcf income to pay off all of its debts.
ALNSE has a Debt to FCF ratio of 0.65. This is amongst the best in the industry. ALNSE outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ALNSE is not too dependend on debt financing.
ALNSE has a better Debt to Equity ratio (0.12) than 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Altman-Z 4.37
ROIC/WACC1.41
WACC7.77%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.77 indicates that ALNSE should not have too much problems paying its short term obligations.
ALNSE's Current ratio of 1.77 is amongst the best of the industry. ALNSE outperforms 85.42% of its industry peers.
A Quick Ratio of 1.31 indicates that ALNSE should not have too much problems paying its short term obligations.
ALNSE has a Quick ratio of 1.31. This is amongst the best in the industry. ALNSE outperforms 85.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.31
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

ALNSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.26%.
Measured over the past years, ALNSE shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.31% on average per year.
The Revenue has grown by 34.51% in the past year. This is a very strong growth!
ALNSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%

3.2 Future

The Earnings Per Share is expected to grow by 29.23% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.73% on average over the next years. This is quite good.
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

ALNSE is valuated quite expensively with a Price/Earnings ratio of 37.72.
The rest of the industry has a similar Price/Earnings ratio as ALNSE.
Compared to an average S&P500 Price/Earnings ratio of 27.06, ALNSE is valued a bit more expensive.
With a Price/Forward Earnings ratio of 22.94, ALNSE is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ALNSE is valued a bit cheaper than 68.75% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALNSE to the average of the S&P500 Index (22.64), we can say ALNSE is valued inline with the index average.
Industry RankSector Rank
PE 37.72
Fwd PE 22.94
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

89.58% of the companies in the same industry are more expensive than ALNSE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALNSE is valued cheaply inside the industry as 97.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.9
EV/EBITDA 12.68
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ALNSE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALNSE's earnings are expected to grow with 29.23% in the coming years.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y29.23%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALNSE has a yearly dividend return of 0.64%, which is pretty low.
ALNSE's Dividend Yield is comparable with the industry average which is at 1.18.
With a Dividend Yield of 0.64, ALNSE pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

On average, the dividend of ALNSE grows each year by 22.60%, which is quite nice.
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

21.90% of the earnings are spent on dividend by ALNSE. This is a low number and sustainable payout ratio.
The dividend of ALNSE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.9%
EPS Next 2Y29.23%
EPS Next 3YN/A
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (9/25/2025, 7:00:00 PM)

43

-0.3 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-23 2025-07-23
Earnings (Next)N/A N/A
Inst Owners20.28%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap145.34M
Analysts86.67
Price Target51 (18.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP21.9%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.6%
PT rev (3m)-0.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.72
Fwd PE 22.94
P/S 1.4
P/FCF 12.9
P/OCF 10.24
P/B 3.48
P/tB 3.97
EV/EBITDA 12.68
EPS(TTM)1.14
EY2.65%
EPS(NY)1.87
Fwd EY4.36%
FCF(TTM)3.33
FCFY7.75%
OCF(TTM)4.2
OCFY9.77%
SpS30.64
BVpS12.35
TBVpS10.83
PEG (NY)1.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROCE 14.62%
ROIC 10.97%
ROICexc 15.46%
ROICexgc 18.16%
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
FCFM 10.88%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexcg growth 3Y-2.2%
ROICexcg growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Debt/EBITDA 0.49
Cap/Depr 86.46%
Cap/Sales 2.83%
Interest Coverage 41.27
Cash Conversion 135.38%
Profit Quality 310.87%
Current Ratio 1.77
Quick Ratio 1.31
Altman-Z 4.37
F-Score5
WACC7.77%
ROIC/WACC1.41
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.7%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y363.17%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y106.8%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%